Prescription RequiredLeuprolide 22.5 mg Injection is a long-acting hormonal medicine used under specialist supervision to lower certain sex hormones in the body. It is commonly used in hormone-sensitive conditions such as prostate cancer and may also be prescribed for other hormone-related conditions depending on the patient’s diagnosis. The 22.5 mg depot strength is generally designed for longer-duration hormone control, often around 3 months, as directed by the doctor.
| Generic name | Leuprolide |
| Strength | 22.5 mg |
| Manufacturer | Zydus Healthcare |
| Package size | 1.0 injection in 1 vial |
| Used for | Prostate cancer, endometriosis, uterine fibroids, and early puberty |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Leuprolide is a GnRH agonist. At first, it may briefly increase hormone levels, but with continuous use, it reduces signals from the brain that stimulate the testes or ovaries. This lowers testosterone in men and estrogen in women, helping control hormone-sensitive diseases.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
